Advertisement

Topics

Zyngenia, Inc. Company Profile

21:12 EST 19th November 2017 | BioPortfolio

Founded in 2008, Zyngenia, Inc. is a privately held biotherapeutics company focused on the development of next-generation multi-specific antibodies. The company uses proprietary patented technology to engineer single molecular entities that may interact with two or more targets. The company will initially focus its Zybody(TM) development on therapies for various cancers and autoimmune disorders. Zyngenia is headquartered in Rockville, Maryland. For more information, visit www.zyngenia.com.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Zyngenia, Inc.

Founded in 2008, Zyngenia, Inc. is a privately held biotherapeutics company focused on the development of next-generation multi-specific antibodies. The company uses proprietary patented technology to...

More Information about "Zyngenia, Inc." on BioPortfolio

We have published hundreds of Zyngenia, Inc. news stories on BioPortfolio along with dozens of Zyngenia, Inc. Clinical Trials and PubMed Articles about Zyngenia, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zyngenia, Inc. Companies in our database. You can also find out about relevant Zyngenia, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...


Corporate Database Quicklinks



Searches Linking to this Company Record